EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Novel Biomarkers of Bone Metabolism

Sara Fernández-Villabrille, Beatriz Martín-Carro iD, Julia Martín-Vírgala, Mª Del Mar Rodríguez-Santamaria, Francisco Baena-Huerta, Juan Rafael Muñoz-Castañeda iD, José Luis Fernández-Martín iD, Cristina Alonso-Montes, Manuel Naves-Díaz, Natalia Carrillo-López iD, Sara Panizo

Nutrients · 2024

DOI: 10.3390/nu16050605 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nutrients, 2024. Verfasst von Sara Fernández-Villabrille und 10 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), 33011 Oviedo, Spain. Hauptthemen laut MEDLINE: Chronic Kidney Disease-Mineral and Bone Disorder, Osteoporosis, Renal Insufficiency, Chronic, Fractures, Bone. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 114 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, Plan de Ciencia, Tecnología e Innovación 2013-2017 y 2018-2022 del Principado de Asturias, Fundación Renal Iñigo Álvarez de Toledo.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bone represents a metabolically active tissue subject to continuous remodeling orchestrated by the dynamic interplay between osteoblasts and osteoclasts. These cellular processes are modulated by a complex interplay of biochemical and mechanical factors, which are instrumental in assessing bone remodeling. This comprehensive evaluation aids in detecting disorders arising from imbalances between bone formation and reabsorption. Osteoporosis, characterized by a reduction in bone mass and strength leading to heightened bone fragility and susceptibility to fractures, is one of the more prevalent chronic diseases. Some epidemiological studies, especially in patients with chronic kidney disease (CKD), have identified an association between osteoporosis and vascular calcification. Notably, low bone mineral density has been linked to an increased incidence of aortic calcification, with shared molecules, mechanisms, and pathways between the two processes. Certain molecules emerging from these shared pathways can serve as biomarkers for bone and mineral metabolism. Detecting and evaluating these alterations early is crucial, requiring the identification of biomarkers that are reliable for early intervention. While traditional biomarkers for bone remodeling and vascular calcification exist, they suffer from limitations such as low specificity, low sensitivity, and conflicting results across studies. In response, efforts are underway to explore new, more specific biomarkers that can detect alterations at earlier stages. The aim of this review is to comprehensively examine some of the emerging biomarkers in mineral metabolism and their correlation with bone mineral density, fracture risk, and vascular calcification as well as their potential use in clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chronic Kidney Disease-Mineral and Bone DisorderOsteoporosisRenal Insufficiency, ChronicFractures, BoneVascular CalcificationHumansBone DensityBiomarkersMinerals

Stichwörter der Autor:innen

biomarkerbone mineral densitychronic kidney diseasevascular calcification

Substanzen

BiomarkersMinerals

Autor:innen und Institutionen

  • Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), 33011 Oviedo, Spain.
  • Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RICORS), RICORS2040 (Kidney Disease), 28040 Madrid, Spain.
  • Bone and Mineral Research Unit, Hospital Universitario Central de Asturias, 33011 Oviedo, Spain.
  • Nephrology Service, Reina Sofia University Hospital, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), University of Córdoba, 14004 Córdoba, Spain.

ORCID-Profile: Beatriz Martín-Carro, Juan Rafael Muñoz-Castañeda, José Luis Fernández-Martín, Natalia Carrillo-López

Förderung

  • Instituto de Salud Carlos III
  • Plan de Ciencia, Tecnología e Innovación 2013-2017 y 2018-2022 del Principado de Asturias
  • Fundación Renal Iñigo Álvarez de Toledo
  • ISCIII Retic REDinREN
  • ISCIII Red de Investigación Cooperativa Orientada a Resultados en Salud RICORS2040
  • Tecnología e Innovación 2013–2017 y 2018–2022 del Principado de Asturias
  • Gobierno del Principado de Asturias
  • Ministerio de Ciencia, Innovación y Universidades

Zitieren

APA

Fernández-Villabrille, S., Martín-Carro, B., Martín-Vírgala, J., Rodríguez-Santamaria, M. D. M., Baena-Huerta, F., Muñoz-Castañeda, J. R., Fernández-Martín, J. L., Alonso-Montes, C., Naves-Díaz, M., Carrillo-López, N., & Panizo, S. (2024). Novel Biomarkers of Bone Metabolism. Nutrients. https://doi.org/10.3390/nu16050605

Vancouver

Fernández-Villabrille S, Martín-Carro B, Martín-Vírgala J, Rodríguez-Santamaria MDM, Baena-Huerta F, Muñoz-Castañeda JR, et al. Novel Biomarkers of Bone Metabolism. Nutrients. 2024. doi:10.3390/nu16050605

BibTeX
@article{FernndezVillabrille2024,
  author = {Fernández-Villabrille, Sara and Martín-Carro, Beatriz and Martín-Vírgala, Julia and Rodríguez-Santamaria, Mª Del Mar and Baena-Huerta, Francisco and Muñoz-Castañeda, Juan Rafael and Fernández-Martín, José Luis and Alonso-Montes, Cristina and Naves-Díaz, Manuel and Carrillo-López, Natalia and Panizo, Sara},
  title = {Novel Biomarkers of Bone Metabolism},
  journal = {Nutrients},
  year = {2024},
  doi = {10.3390/nu16050605}
}
Kostenlos starten →